These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
223 related items for PubMed ID: 2170270
1. Down-regulation of KOLT-2 antigen (CD28) by interleukin 2; role of IL-2R (p70). Shindo T, Sugie K, Nakamura K, Tagaya Y, Maeda M, Uchiyama T, Sagawa K, Yokoyama M, Wada H, Hitomi S. Immunology; 1990 Sep; 71(1):63-9. PubMed ID: 2170270 [Abstract] [Full Text] [Related]
2. Effect of interleukin 1 on the expression of interleukin 2 receptor (Tac antigen) on human natural killer cells and natural killer-like cell line (YT cells). Shirakawa F, Tanaka Y, Eto S, Suzuki H, Yodoi J, Yamashita U. J Immunol; 1986 Jul 15; 137(2):551-6. PubMed ID: 3013994 [Abstract] [Full Text] [Related]
3. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy. Verwilghen J, Vandenberghe P, Wallays G, de Boer M, Anthony N, Panayi GS, Ceuppens JL. J Immunol; 1993 Feb 01; 150(3):835-46. PubMed ID: 7678624 [Abstract] [Full Text] [Related]
8. IL-2 receptor(p55)/Tac-inducing factor. Purification and characterization of adult T cell leukemia-derived factor. Tagaya Y, Okada M, Sugie K, Kasahara T, Kondo N, Hamuro J, Matsushima K, Dinarello CA, Yodoi J. J Immunol; 1988 Apr 15; 140(8):2614-20. PubMed ID: 2895791 [Abstract] [Full Text] [Related]
9. Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype. Weil-Hillman G, Voss SD, Fisch P, Schell K, Hank JA, Sosman JA, Sugamura K, Sondel PM. Cancer Res; 1990 May 01; 50(9):2683-91. PubMed ID: 1691679 [Abstract] [Full Text] [Related]
10. Adult T leukemia cells produce a lymphokine that augments interleukin 2 receptor expression. Teshigawara K, Maeda M, Nishino K, Nikaido T, Uchiyama T, Tsudo M, Wano Y, Yodoi J. J Mol Cell Immunol; 1985 May 01; 2(1):17-26. PubMed ID: 2978223 [Abstract] [Full Text] [Related]
17. Mitogenicity and down-regulation of high-affinity interleukin 2 receptor by YTA-1 and YTA-2, monoclonal antibodies that recognize 75-kDa molecules on human large granular lymphocytes. Nakamura Y, Inamoto T, Sugie K, Masutani H, Shindo T, Tagaya Y, Yamauchi A, Ozawa K, Yodoi J. Proc Natl Acad Sci U S A; 1989 Feb 01; 86(4):1318-22. PubMed ID: 2465549 [Abstract] [Full Text] [Related]
18. Cooperation between an anti-T cell (anti-CD28) monoclonal antibody and monocyte-produced IL-6 in the induction of T cell responsiveness to IL-2. Baroja ML, Ceuppens JL, Van Damme J, Billiau A. J Immunol; 1988 Sep 01; 141(5):1502-7. PubMed ID: 3261751 [Abstract] [Full Text] [Related]
19. Functional effects of CD30 on a large granular lymphoma cell line, YT. Inhibition of cytotoxicity, regulation of CD28 and IL-2R, and induction of homotypic aggregation. Bowen MA, Olsen KJ, Cheng L, Avila D, Podack ER. J Immunol; 1993 Dec 01; 151(11):5896-906. PubMed ID: 8245437 [Abstract] [Full Text] [Related]
20. Presence of a p70 IL-2-binding peptide on leukemic cells from various hemopoietic lineages. Allouche M, Sahraoui Y, Augery-Bourget Y, Ohashi Y, Sugamura K, Jasmin C, Georgoulias V. J Immunol; 1989 Oct 01; 143(7):2223-9. PubMed ID: 2789258 [Abstract] [Full Text] [Related] Page: [Next] [New Search]